The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.
about
Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administrationMechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient miceNewer insights into the pathogenesis of experimental autoimmune thyroiditis.Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.CD28-independent induction of experimental autoimmune encephalomyelitis.Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes.Modulating co-stimulation.Translating costimulation blockade to the clinic: lessons learned from three pathways.Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process.Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.Nucleosome-driven autoimmune response in lupus. Pathogenic T helper cell epitopes and costimulatory signals.Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis.Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis.Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
P2860
Q33783991-79DA2C06-FAC4-4933-90EB-54017C94D869Q33835268-9E5B16CE-8329-4497-B0F2-9ADD723EAEB2Q34004385-18B505F8-0E3F-494E-8A88-9D666D1E7335Q34112871-2F3D8406-322E-4992-A2D3-3C418E08BC5AQ34787127-7A717C21-AA62-47E4-B9CA-38346BF331E2Q35994774-16836D41-D2B7-4087-AE3F-C1A66294CA48Q36013773-63A0D08C-DC01-4442-87F4-71EEBAADA929Q36376757-5E17DB30-F373-481E-9E42-17FA66520675Q36963201-ADC4923C-69E3-4456-8996-92FB0603C5ABQ37474964-90581A86-8B91-42BC-97C8-412002943766Q38499559-26C4393F-388B-4DAB-B6D6-9AFF784EBD71Q39601191-E0AEC434-0C35-48A5-B685-C6365662D297Q41500830-05898356-17D3-41E7-BB3D-655BA8130AA2Q41830915-468E4304-5627-4697-B511-72C28D34386CQ48003970-A5039EC5-D5B8-449B-A158-584469F78F26Q48648841-D11C3776-5D3A-43F2-A894-7D0E535CF6ADQ48957526-F6070BB5-45EF-4C2E-9923-C0FA5C029148Q54059237-3175C6A7-D607-4A9F-A53B-15F3B2DF9BF5
P2860
The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The relative contribution of t ...... tion of self-reactive T cells.
@ast
The relative contribution of t ...... tion of self-reactive T cells.
@en
type
label
The relative contribution of t ...... tion of self-reactive T cells.
@ast
The relative contribution of t ...... tion of self-reactive T cells.
@en
prefLabel
The relative contribution of t ...... tion of self-reactive T cells.
@ast
The relative contribution of t ...... tion of self-reactive T cells.
@en
P2093
P2860
P356
P1476
The relative contribution of t ...... tion of self-reactive T cells.
@en
P2093
J A Ledbetter
N D Griggs
P S Linsley
R J Noelle
S S Agersborg
P2860
P304
P356
10.1084/JEM.183.3.801
P407
P577
1996-03-01T00:00:00Z